baber/WOPTO huggingface dataset:
Patent CA-3049692-A1 (CA)
Title: Bone implant with struts
Inventor: TUTTLE DAVID R
IPC: A61F2/00
Filed: 2018-03-27
Abstract: An implant includes a component for fixed attachment to a bone. An underpass layer of a porous material is disposed on a first side of the component for fixed attachment. At least one strut is provided on the underpass layer. The at least one strut has a first surface contacting the underpass layer and a second surface opposite the first surface. The at least one strut comprises a non-porous material. An additional layer of the porous material fills a respective volume adjacent the at least one strut. The additional layer extends from a first side of the underpass layer to a predetermined height at or above the second surface of the at least one strut.
Patent CA-3050905-A1 (CA)
Title: Diffuseurs en tissu suspendus
Inventor: SCHMIDT BLAINE
IPC: F24F13/06
Filed: 2018-01-19
Abstract: L'invention concerne des diffuseurs abaissés en tissu. Un exemple de diffuseur abaissé comprend un panneau supérieur comprenant une feuille de tissu supérieure destinée à être maintenue en tension radiale au moyen d'un arceau supérieur. Le panneau supérieur délimite une entrée d'air d'alimentation. Le diffuseur abaissé donné à titre d'exemple comprend en outre un panneau inférieur destiné à être situé sous le panneau supérieur et espacé de celui-ci. Le diffuseur abaissé donné à titre d'exemple comprend également une feuille de tissu circonférentielle destinée à encercler le panneau supérieur et le panneau inférieur. La feuille de tissu circonférentielle doit s'étendre vers le bas depuis le panneau supérieur jusqu'au panneau inférieur de sorte à délimiter une chambre à air bordée par le panneau supérieur, le panneau inférieur et la feuille de tissu circonférentielle. La chambre à air est raccordée en communication fluidique avec l'entrée d'air d'alimentation.
Patent CA-3051963-A1 (CA)
Title: Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflection corrections
Inventor: SCHULTZ KIMBERLY
IPC: A61B5/00
Filed: 2018-01-30
Abstract: A method of monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a medium with time-varying optical properties is provided that includes providing a measurement data set that includes a plurality of measurement entries that include at least two measurements obtained from a patient before and after administration of the fluorescent agent. The measurements may include one or more of: a DR ex signal detected by an unfiltered light detector during illumination by excitatory-wavelength light from first region adjacent to the diffuse reflecting medium; a Flr signal detected by a filtered light detector during illumination by excitatory-wavelength light; and a DR em signal detected by the unfiltered light detector during illumination by emission-wavelength light. The method further includes identifying a post-agent administration portion of the measurement data set; and transforming each Flr signal to an IF signal representing a detected fluorescence intensity emitted solely by the fluorescent agent.
Patent CA-3056756-A1 (CA)
Inventor: UEDA HIROKI
IPC: C12N15/09
Filed: 2018-03-15
Abstract: Provided are a method for efficiently obtaining a complex, in which a gene (mRNA) and a peptide, said peptide being a translation product of the gene, are linked via a peptide receptor molecule, and utilization thereof. In the method according to the present invention, at least one 2'-modified nucleoside derivative is introduced into the 5'-terminal side of the antisense strand of a template DNA.
Patent CA-3062092-A1 (CA)
Title: Battery-operated smart metering counter
Inventor: PETKOV HRISTO
IPC: H04W52/02
Filed: 2018-04-11
Abstract: During the battery operation of a smart metering meter (11) which is equipped with a consumption sensor (14) and a transmit clock generator (17) for a radio module (19) for the transmission of consumption data packets (20), in the event of a conspicuously decreased residual capacity of the battery (21), it is determined whether the data packets (20) can be transmitted as previously with said residual capacity over the residual time period also until the scheduled battery exchange at the end of the specified operating time period. If not, the transmit power, for example, of the data packets (20) is reduced and/or their transmit clock (27) is extended over the residual period. This determination, along with the control specification, are preferably performed in the concentrator (13) and are transmitted by means of bidirectionally operating radio modules (19) to the meter (11) so that the computer capacities required for this purpose do not have to be retained in each individual meter (11) of the supply area.
Patent CA-3066166-A1 (CA)
Title: New substituted azaindoline derivatives as nik inhibitors
Inventor: HYND GEORGE
IPC: C07D471/04
Filed: 2018-07-04
Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis m a mammal, and m particular to inhibitors of NF-.kappa. B-inducing kinase (NIK - also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders
Patent CA-3066457-A1 (CA)
Title: Flex duct fitting system and device
Inventor: QUINN DION EDWARD
IPC: F24F7/04
Filed: 2020-01-03
Abstract: A flex duct fitting system includes: a flex duct with an inner lining, a flex duct fitting device, including a connector portion, including a connector portion body, a flex fitting assembly with a peripheral protrusion and a peripheral indentation; a circular fastener, such that the inner lining is pulled over the flex fitting assembly, such that the at least one circular fastener is positioned in the peripheral indentation and tightened around the connector portion body, with the inner lining tightened in place between the at least one circular fastener and the peripheral indentation.
Patent CA-3068249-A1 (CA)
Title: Radial-capitellar implant
Inventor: SCHREIBER ULRICH
IPC: A61F2/46
Filed: 2018-06-04
Abstract: The invention relates to a radial-capitellar implant having a head, a stem and a threaded anchor.
Patent CA-3069132-A1 (CA)
Title: Electrode binder slurry composition for lithium ion electrical storage devices
Inventor: HELLRING STUART D
IPC: H01M4/04
Filed: 2018-07-06
Abstract: The present invention provides a slurry composition comprising a binder comprising a polymer comprising a fluoropolymer dispersed in a liquid medium; an adhesion promoter; and at least one of an electrochemically active material or an electrically conductive agent. The present invention also provides electrodes and electrical storage devices.
Patent CA-3069952-A1 (CA)
Title: Process for determining viability of test microorganisms of biological indicator and sterilization detection device for determining same
Inventor: FRANCISKOVICH PHILLIP P
IPC: G01N27/04
Filed: 2018-07-11
Abstract: A process for determining the viability of a biological indicator includes exposing the biological indicator to a viability detection medium, the biological indicator including test microorganisms, the exposing the biological indicator to the viability detection medium producing a gaseous reaction product when one or more of the test microorganisms are viable. The presence or absence of the gaseous reaction product produced by the biological indicator combined with the viability detection medium is detected with a sensing device, the sensing device comprising a resistive sensor, wherein the presence of the gaseous reaction product indicates the presence of viable test microorganisms and the absence of the gaseous reaction product indicates the absence of viable test microorganisms. A sterilization detection device includes a container configured to contain the biological indicator, a viability detection medium, and the sensing device.
Patent CA-3071653-A1 (CA)
Title: System and method for pressurizing a grow pod
Inventor: MILLAR GARY BRET
IPC: A01G31/04
Filed: 2018-05-24
Abstract: A method and system for pressurizing an assembly line grow pod system is provided. The method includes arranging a dual wall including an outer wall (420) and an inner wall (430), controlling, with an air pressure controller (410), first air pressure in a first sealed area (442) and second air pressure in a second sealed area (444), and controlling, with a master controller (106), operations of the air pressure controller (410). The first air pressure of the first sealed area (442) is controlled to be higher than pressure of an exterior area to the outer wall (420) by a predetermined amount.
Patent CA-3075287-A1 (CA)
Inventor: OLSON ALLEN
IPC: G02B21/00
Filed: 2018-09-28
Abstract: L'invention concerne un appareil de balayage numérique qui comprend des capteurs d'imagerie et de mise au point, et un processeur pour analyser les données d'image capturées par les capteurs d'imagerie et de mise au point et pour régler la mise au point de l'appareil de balayage en temps réel pendant une opération de balayage. Les pixels individuels du capteur d'imagerie se trouvent tous dans le même plan d'image par rapport au trajet optique de l'appareil de balayage numérique. Les pixels individuels du capteur de mise au point se trouvent chacun dans un plan d'image différent par rapport au trajet optique, et un pixel du capteur de mise au point se trouve sur le même plan d'image que le capteur d'image. Le processeur analyse des données d'image provenant du capteur d'imagerie et du capteur de mise au point et détermine une distance et une direction pour régler la position relative d'une lentille d'objectif et d'un étage de l'appareil de balayage numérique afin d'obtenir une mise au point optimale pendant l'opération de balayage.
Patent CA-3075442-A1 (CA)
Inventor: WILSON DARIUS
IPC: G01N33/569
Filed: 2018-09-13
Abstract: The invention relates to a method for antibiotic therapy guidance, stratification and/or control in a patient suffering from an infectious disease and receiving treatment with one or more antibiotic agents. In particular, the method comprises isolating a first sample from said patient, isolating a second sample from said patient after isolating the first sample and initiating antibiotic treatment, determining levels of procalcitonin (PCT) or fragment(s) thereof in the first and the second sample, and determining a level of proadrenomedullin (proADM) or fragment(s) thereof in at least the second sample, wherein the levels of PCT or fragment(s) thereof in said first and second samples, and the level of pro ADM or fragment(s) thereof in the second sample, are indicative of whether a change in the treatment with one or more antibiotic agents is required. In a preferred embodiment of the invention, the method comprises additionally determining a level of pro ADM or fragment(s) thereof in the first and second samples. In a preferred embodiment of the invention changes in the pro ADM and PCT levels between the first and second samples indicate a need for changing or maintaining the antibiotic treatment. Furthermore, the invention also relates to a kit for carrying out the method of the present invention.
Patent CA-3075973-A1 (CA)
Inventor: GADDIPATI SANYASI
IPC: A23L33/105
Filed: 2018-10-22
Abstract: The invention relates to a manufacturing process for the production of a lipid-fiber powder. In particularly the invention relates to a process for the production of a lipid-fiber powder having between 40 to 78wt% of oil or fat (by weight of total lipid-fiber powder) and 22 to 60wt% of a vegetable fiber (by weight of total lipid-fiber powder), wherein the fiber is characterized by having a rate of hydration between 15 to 500 cP/min and wherein the oil or fat has a solid fat content (SFC) at 20°C below 12 wt%.
Patent CA-3077970-A1 (CA)
Inventor: CAVALLINI ALESSIO
IPC: G06V40/40
Filed: 2012-07-03
Abstract: The present disclosure concerns a method of verifying the presence of a living face in front of a camera (112), the method comprising: capturing by said camera a sequence of images of a face; detecting a plurality of features of said face in each of said images; measuring parameters associated with said detected features to determine whether each of a plurality of liveness indicators is present in said images; determining whether or not said face is a living face based on the presence in said images of a combination of at least two of said liveness indicators.
Patent CA-3078602-A1 (CA)
Title: Epidermal growth factor receptor inhibitors
Inventor: ZAVIALOV KIRILL VADIMOVICH
IPC: A61K31/506
Filed: 2018-10-05
Abstract: The present group of inventions relates to novel compounds having formula (I), and to the salts, solvates or stereoisomers thereof, as well as to a pharmaceutical composition, a method of inhibiting the biological activity of epidermal growth factor receptor (EGFR), a method of treating diseases or disorders mediated by EGFR activity, and the use of the claimed compounds or the aforementioned composition for treating a disease or a disorder mediated by EGFR activity.
Patent CA-3079784-A1 (CA)
Title: Biogenic oliogomers as reactive additives for the curing of reactive resins
Inventor: BUNZEN JENS
IPC: C08F222/10
Filed: 2018-11-19
Abstract: The present invention relates to a reactive resin comprising a vinyl ester resin as a base resin and an oligomeric itaconic acid ester as a reactive diluent.
Patent CA-3080211-A1 (CA)
Title: Four a recirculation d'atmosphere controlee
Inventor: GOODEN BRIAN PHILIP
IPC: F27B5/14
Filed: 2018-11-01
Abstract: La présente invention concerne un appareil utile dans le traitement d'un matériau précurseur de fibre de carbone dans des conditions prédéterminées de température et d'environnement gazeux. L'invention peut être mise en uvre sous la forme d'un appareil pour traiter un matériau précurseur de fibre de carbone comprenant un boîtier, et une chambre de réaction disposée à l'intérieur du boîtier. La chambre de réaction est allongée et comporte un orifice d'entrée à une première extrémité et un orifice de sortie à une deuxième extrémité. Les orifices d'entrée et de sortie sont configurés pour permettre le passage d'un matériau précurseur de fibre de carbone dans et hors de la chambre de réaction respectivement, et un dispositif de chauffage ou un système de chauffage est configuré pour chauffer une paroi de la chambre de réaction. En cours d'utilisation, un matériau précurseur est passé à travers la chambre de réaction et est ainsi chauffé.
Patent CA-3080501-A1 (CA)
Title: Motorized actuator and movable barrier provided with said actuator, particularly suitable for auxiliary or emergency drives
Inventor: ACETO DANILO
IPC: E05F15/603
Filed: 2020-05-08
Abstract: The motorized drive (5) according to the invention is particularly suitable for auxiliary or emergency drives and is configured to open or close a wing (3) of a barrier such as a door. The motorized drive (5) comprises a motor (7) and a reduction unit (9) through which the motor (7) can open or close the wing (3), an auxiliary motor (7') comprising a helical spring (19) which is able to absorb mechanical energy during the opening of the wing (3) and release it during the closing of the same, a reduction unit (9') connecting the auxiliary motor (7') to the wing (3). A first (11, 11') and a second toothed profile (13, 13') realize a gear with a variable transmission ratio. The first (11, 11') and/or the second toothed profile (13, 13') form at least one toothing having a pitch profile which is substantially non-circular or not formed by a simple arc of a circle or a straight line.
Patent CA-3083101-A1 (CA)
Inventor: KANG SINWOOK
IPC: C07K14/575
Filed: 2018-11-23
Abstract: The present invention relates to a composition for promoting goblet cell proliferation or mucin secretion comprising thymosin beta-4, an isoform of thymosin beta-4, an analogue thereof, or a derivative of thymosin beta-4 as an active ingredient.  The composition for promoting mucin secretion comprising thymosin beta-4, an isoform thereof or derivative thereof as an active ingredient according to the present invention promotes goblet cell proliferation and increases a mucin secretion amount.  In particular, the composition for promoting mucin secretion increases the expression of Muc5AC, Muc1, Muc4, and Muc16. Therefore, the composition for promoting goblet cell proliferation or mucin secretion of the present invention is considered to have an excellent effect on goblet cell or mucin-related diseases.
Patent CA-3086188-A1 (CA)
Inventor: WADSWORTH SAM
IPC: A61L27/18
Filed: 2018-12-20
Abstract: Provided herein are meniscus implant compositions, as well as method for making and using the same. The subject meniscus implants find use in repairing and/or replacing damaged or diseased meniscal tissue in a mammalian subject.
Patent CA-3094939-A1 (CA)
Title: Dipeptide piperidine derivatives
Inventor: BLASZCZYK ROMAN
IPC: C07K5/02
Filed: 2019-03-29
Abstract: The disclosure relates to pharmaceutical compositions, to methods of preparing such compositions, and to methods for using such compositions for treating or preventing a disease or condition associated with arginase activity.
Patent CA-3095072-A1 (CA)
Title: Needleless connector loosening device
Inventor: CHIANG TE CHIH
IPC: A61M39/02
Filed: 2020-02-04
Abstract: A tool for loosening a needleless connector is provided. The tool is a holder for holding a catheter port connected to the needleless connector. The holder includes a front surface, a rear surface, a top surface, and a cavity. The cavity accommodates the catheter port. The cavity extends through the holder and has a front opening in the front surface, a rear opening in the rear surface, and a rear inner wall. The cavity is defined by at least a first cross-sectional dimension and a second cross-sectional dimension, the first cross-sectional dimension at least partially defining a front section opening to the front opening, the second cross-sectional dimension at least partially defining a rear section opening to the rear opening.
Patent CA-3095596-A1 (CA)
Title: Pressure based blood vessel assessment systems and methods
Inventor: BELLEVILLE CLAUDE
IPC: A61B5/02
Filed: 2019-04-02
Abstract: A system for assessing a vascular condition includes a pressure sensing catheter and a pressure guidewire. Heartbeats of the patient can be detected while the pressure sensing catheter and the pressure guidewire are positioned at the proximal position and at a distal position respectively. A diastolic pressure ratio zone (dPR zone) is located within a heartbeat from analysis of a signal from at least one of the pressure sensing catheter and the pressure guidewire. The dPR value can be obtained by calculating an average of several ratios of Pa to Pd taken over time within the heartbeat. A multi-beat metric (dPRc) is calculated that includes the dPR value and that also includes a high frequency sample whole heartbeat pressure ratio.
Patent CA-3098857-A1 (CA)
Title: Track system for a vehicle having at least three axles, vehicle comprising the same and pivoting assemblies adapted for connection between a frame of a track system and an axle of a vehicle
Inventor: AUBIN-MARCHAND JEREMIE
IPC: B62D55/04
Filed: 2020-11-12
Abstract: ABSTRACT A track system for a vehicle having at least three axles is disclosed. The track system includes a frame to which sprocket, idler and support wheel assemblies are connectable, an endless track and a pivoting assembly. The pivoting assembly has a casing .. connectable to a second axle and at least one pivotable member that has first and second portions respectively pivotally connected to the casing and to the frame. The at least one pivotable member is pivotable between first and second positions about a longitudinally extending pivot, in response to which the first portion is displaced laterally relative to the second portion, and pivotable between third and fourth positions about a lateral pivot axis in response to which the first portion is displaced longitudinally relative to the second portion. A pivoting assembly, a pivoting assembly including a resilient assembly, and a vehicle having the track system are also disclosed. 15909898.1 Date Recue/Date Received 2020-11-12
Patent CA-3102395-A1 (CA)
Title: Topical compositions for stimulating hair growth
Inventor: BRICHTA LARS
IPC: A61K31/277
Filed: 2019-06-04
Abstract: Compositions and methods for treating hair loss and/or nail brittleness, fragility, and pitting, particularly in pediatric patients, using topically administered JAK/STAT inhibitors and one or more penetration enhancer are described herein.
Patent CA-3103111-A1 (CA)
Inventor: CHEN YU
IPC: C08L23/22
Filed: 2019-09-11
Abstract: L'invention concerne une composition destinée à être utilisée en tant que matériau d'interface thermique dans un dispositif de génération de chaleur. La composition comprend une première partie et une seconde partie, la première partie comprenant du polyisobutylène, un mélange de diluants réactif, un catalyseur et une ou plusieurs charges thermoconductrices, et la seconde partie comprenant du polyisobutylène, le mélange de diluants réactif, un agent de réticulation à base de silicone, un inhibiteur et une ou plusieurs charges thermoconductrices.
Patent CA-3103705-A1 (CA)
Inventor: O'SHEA ALAN MICHAEL
IPC: E04G3/24
Filed: 2019-06-24
Abstract: An apparatus and related kit for forming the apparatus that includes a modular perimeter guardrail assembly useful on top of electrical transformers found in industrial settings. The apparatus and kit combines anchors, posts, braces, and midrail clamps that are able to be assembled by a worker quickly, safely and intuitively. The apparatus may be assembled, disassembled, and reassembled any given configuration of the guardrail apparatus on the same or different transformer and serves to prevent workers from falling off the top of the given transformer. The apparatus may be installed on an electrical transformer having post supports permanently affixed thereto for removeable attachment of post assemblies.
Patent CA-3106952-A1 (CA)
Inventor: VERLINDEN STEFAN FREDERIK FRANCISCUS
IPC: A61K31/121
Filed: 2019-07-24
Abstract: Provided herein are means and methods for inhibiting processes and/or facilitating processes in cells by means of a compound of structural formula (I) wherein R1, R2, R3, R4, R5 and R6 are each independently H, OH, CH3, OCH3, a monosaccharide, an oligosaccharide or Cl; with the proviso that at least two of R1- R6 are H; and at least one other of R1-R6 is OH. The compound can be used among others in the prophylactic or curative treatment of an elevated blood interleukin-1ß level and/or the treatment of low grade inflammation in an animal subject in need thereof. Also provided is a method for increasing longevity or increasing the health span in a non-diseased animal subject, the method comprising administering to the animal subject an effective amount of a hydroxychalcone of formula I as indicated herein. Also provided are food and food supplements comprising a compound of formula I as indicated herein.
Patent CA-3108526-A1 (CA)
Title: Variant rnai against alpha-synuclein
Inventor: ELMER BRADFORD
IPC: C12N15/113
Filed: 2019-08-02
Abstract: Provided herein are RNAi molecules for treating neurodegenerative synucleinopathies. In some embodiments, the RNAi molecules target expression of alpha-synuclein (SNCA). Further provided herein are expression constructs, vectors ( e.g rAAV), cells, viral particles, and pharmaceutical compositions containing the RNAi. Yet further provided herein are methods and kits related to the use of the RNAi, for example, to treat neurodegenerative synucleinopathies including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies.